CTC
VRCA icon

Cetera Trust Company’s Verrica Pharmaceuticals VRCA Stock Holding History

Cetera Trust Company’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$7.29K – 411
2024
Q2 		$7.29K Hold
100
– – ﹤0.01% 329
2024
Q1 		$5.92K Hold
100
– – ﹤0.01% 360
2023
Q4 		$7.32K Buy
+100
New +$4.11K ﹤0.01% 326

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cetera Trust Company's VRCA Position: Q3 2024 in Review

Cetera Trust Company sold out of Verrica Pharmaceuticals (VRCA) in Q3 2024, closing a stake of 100 shares — an estimated $7.29K sold.

Cetera Trust Company first reported a position in VRCA in Q4 2023 and held it in 3 quarters. The position peaked at $7.32K in Q4 2023. 79 funds tracked by Wall St. Rank hold VRCA as of Q3 2024.

  • Cetera Trust Company reported no remaining Verrica Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Cetera Trust Company sold 100 Verrica Pharmaceuticals shares in Q3 2024, an estimated $7.29K.
  • Cetera Trust Company first reported a position in Verrica Pharmaceuticals in Q4 2023 and held it in 3 quarters.
  • Cetera Trust Company's Verrica Pharmaceuticals position peaked at $7.32K in Q4 2023.
  • 79 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2024.

Based on Cetera Trust Company's 13F filing for Q3 2024, filed 21 Oct 2024.